| known also as: |
C-term, Anti-PAX7 antibody [C3] |
| known also as: |
Anti- [C3], C-term, PAX7 |
| known also as: |
C-term, PAX7 antibody [C3] |
| known also as: |
PAX7 [C3] |
| known also as: |
FLJ37460, HUP1, PAX7, PAX7 transcriptional factor, PAX7B, RMS2, paired box 7, paired box 7, paired box homeotic gene 7, paired box protein Pax-7, paired domain gene 7, Rabbit Polyclonal antibody to PAX7 (paired box 7) |
| Other names: |
HuP1, PAX7 transcriptional factor, Paired box protein Pax-7, paired box 7, paired box homeotic gene 7, paired box protein Pax-7, paired domain gene 7, paired box protein Pax-7 isoform 1 |
| Gene name: |
PAX7 |
| Other gene names: |
HUP1, HUP1, PAX7, PAX7B, RMS2, PAX7 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Rabbit |
| Species reactivity: |
Human |
| Purification method: |
Purified by antigen-affinity chromatography |
| Form/Appearance: |
Liquid |
| Concentration: |
1 miligram per 1 mililiter |
| Storage and shipping: |
Aliquot and store at -20 degrees Celsius, Multiple freeze-thaw cycles should be avoided as they may damage the peptide chains and/or other components and reduce the activity, The product should be kept as concentrated solution |
| Tested for:: |
Western Blot (WB), Immunohistochemistry (IHC) Paraffin |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| French translation: |
anticorps |
| Gene target: |
PAX7 [C3] C-term |
| Short name: |
PAX7 antibody [C3] C-term |
| Alternative name: |
c terminus, paired box 7 (Antibody to) [complement component 3] |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, BT, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, DNA-templated and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0009653 and anatomical structure morphogenesis and biological process this GO :0010453 and regulation of cell fate commitment and biological process this GO :0010468 and regulation of gene expression and biological process this GO :0014813 and satellite cell commitment and biological process this GO :0021527 and spinal cord association neuron differentiation and biological process this GO :0021904 and dorsal/ventral neural tube patterning and biological process this GO :0031062 and positive regulation of histone methylation and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043393 and regulation of protein binding and biological process this GO :0043403 and skeletal muscle tissue regeneration and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048663 and neuron fate commitment and biological process this GO :0048706 and embryonic skeletal system development and biological process this GO :0051216 and cartilage development and biological process this GO :0060415 and muscle tissue morphogenesis and biological process this GO :2000288 and positive regulation of myoblast proliferation and biological process, Extracellular, HUP1 and PAX7B and RMS2, PAX7 and IDBG-645775 and ENSBTAG00000014967 and 536229, PAX7 and IDBG-92024 and ENSG00000009709 and 5081, Pax7 and IDBG-201015 and ENSMUSG00000028736 and 18509, alternative pathway and biological process this GO :0006958 and complement activation, classical pathway and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0010575 and positive regulation vascular endothelial growth factor production and biological process this GO :0010828 and positive regulation of glucose transport and biological process this GO :0010866 and regulation of triglyceride biosynthetic process and biological process this GO :0010884 and positive regulation of lipid storage and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0031715 and C5L2 anaphylatoxin chemotactic receptor binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045745 and positive regulation of G-protein coupled receptor protein signaling pathway and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0050776 and regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, nuclei, paired box 7, sequence-specific DNA binding, this GO :0000983 and RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity and molecular function this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0006338 and chromatin remodeling and biological process this GO :0006355 and regulation of transcription, this GO :0000983 : RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity, this GO :0000983 : RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity and also this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding and also this GO :0043565 : sequence-specific DNA binding, this GO :0001798 and positive regulation of type IIa hypersensitivity and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001970 and positive regulation of activation of membrane attack complex and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006631 and fatty acid metabolic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006956 and complement activation and biological process this GO :0006957 and complement activation, this GO :0003677 : DNA binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0005515 : protein binding, this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0043565 : sequence-specific DNA binding, 12266, 19562 and IDBG-643930 and ENSBTAG00000017280 and 280677, complement component 3 |
| Identity: |
8621 |
| Gene: |
PAX7 |
More about : PAX7 |
| Long gene name: |
paired box 7 |
| Synonyms gene name: |
paired box gene 7 |
| Synonyms: |
Hup1 |
| Locus: |
1p36, 13 |
| Discovery year: |
1992-11-20 |
| GenBank acession: |
X96743 |
| Entrez gene record: |
5081 |
| Pubmed identfication: |
7981748 8431641 |
| RefSeq identity: |
NM_002584 |
| Classification: |
PRD class homeoboxes and pseudogenes Paired boxes |
| Havana BLAST/BLAT: |
OTTHUMG00000002433 |